A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis
Abstract The purpose of this pilot study was to explore the efficacy, safety, and tolerability of vidofludimus calcium (VC) in the treatment of primary sclerosing cholangitis (PSC). This was a single‐arm open‐label pilot study with a cohort of 18 patients with PSC. Study patients received VC for a p...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2022-07-01
|
| Series: | Hepatology Communications |
| Online Access: | https://doi.org/10.1002/hep4.1926 |